BioPhausia reschedules bank loan
(Thomson Reuters ONE) -
BioPhausia's bank credit has been extended, and the Company has rescheduled its
bank loan. The bank increased BioPhausia's credit facility by SEK 50 million in
response to the Company's new supply contracts with two leading pharmacy chains.
On Friday, BioPhausia announced that it had signed long-term supply contracts
with Apoteksgruppen and another large pharmacy chain for the delivery of
parallel-imported drugs. The parallel trade represents an important business
area for BioPhausia and the two agreements are expected to give the Company's
sales a considerable boost.
"It is encouraging to see the bank supporting the Company's growth and
expansion," says BioPhausia's CEO Claes Thulin. "Our increased credit facility
is attributable to the signing of agreements with two important customers and
the value of these agreements to the Company's future growth."
For more information, please contact:
Claes Thulin, CEO, tel +46 (0)8-4076430
Henrik Wetterdal, CFO, tel +46 (0)8-4076430
[HUG#1414873]
BioPhausia reschedules bank loan: http://hugin.info/130049/R/1414873/366112.pdf
Unternehmensinformation / Kurzprofil:
Datum: 11.05.2010 - 15:58 Uhr
Sprache: Deutsch
News-ID 20696
Anzahl Zeichen: 0
contact information:
Town:
Stockholm
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 206 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"BioPhausia reschedules bank loan"
steht unter der journalistisch-redaktionellen Verantwortung von
BioPhausia AB (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
